Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. Johnson & Johnson (NYSE:JNJ) has long been considered one of the most dependable dividend stocks, ...

Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer shared insights on. Cramer discussed the company stock in ...

Johnson & Johnson (NYSE:JNJ) is one of the most undervalued NYSE stocks to buy now. On July 8, Johnson & Johnson announced ...

"No More Tears," by Gardiner Harris, is a scathing expose of Johnson & Johnson and its many missteps and transgressions.

Millions of dollars in treatments, supplements, and scans. Immortality through AI. Bryan Johnson’s longevity script has ...

A naturally occurring mineral, talc consists of several elements like magnesium and silicon. When ground into fine particles, talc becomes talcum powder, which works to absorb moisture and soothe the ...

The healthtech firm is broadening its rapid diagnostics and wellness portfolio amid rising demand for preventive, home-based healthcare in India ...

The company reports adjusted earnings of $2.77 a share for the second quarter, beating analysts’ estimates of $2.68.

When Manish Anandani introduces himself as the managing director of Kenvue India, the first question he often gets is, “What is Kenvue?” It’s a fair ask. While the name may be relatively new, the ...

J&J’s shares have outperformed the industry year to date. The stock has risen 15.1% in the year-to-date period against a 0.5% ...

He helped grow Long Island's largest public company from $225M to $13B in annual revenue after joining in 1989.